{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:25:50Z","timestamp":1781969150473,"version":"3.54.5"},"reference-count":13,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.25-0555","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T22:09:49Z","timestamp":1766441389000},"page":"n\/a","source":"Crossref","is-referenced-by-count":2,"title":["Conversion Surgery after Complete Response to Immune Checkpoint Inhibitor-Based Sequential Chemotherapy for Initially Unresectable Perihilar Cholangiocarcinoma: A Case Report"],"prefix":"10.70352","volume":"11","author":[{"given":"Takahiro","family":"Tomino","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Sugimachi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadatoshi","family":"Kakimoto","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Shin-Koga Hospital, Kurume, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507\u201319; discussion 517\u20139.","DOI":"10.1097\/00000658-200110000-00010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245: 755\u201362.","DOI":"10.1097\/01.sla.0000251366.62632.d3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Matsuo K, Rocha FG, Ito K, et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 2012; 215: 343\u201355.","DOI":"10.1016\/j.jamcollsurg.2012.05.025"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nuzzo G, Giuliante F, Ardito F, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 2012; 147: 26\u201334.","DOI":"10.1001\/archsurg.2011.771"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg 2013; 258: 129\u201340.","DOI":"10.1097\/SLA.0b013e3182708b57"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ebata T, Mizuno T, Yokoyama Y, et al. Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. Br J Surg 2018; 105: 829\u201338.","DOI":"10.1002\/bjs.10556"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273\u201381.","DOI":"10.1056\/NEJMoa0908721"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ioka T, Kanai M, Kobayashi S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA). J Hepatobiliary Pancreat Sci 2023; 30: 102\u201310.","DOI":"10.1002\/jhbp.1219"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid 2022; 1: EVIDoa2200015.","DOI":"10.1056\/EVIDoa2200015"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023; 401: 1853\u201365.","DOI":"10.1016\/S0140-6736(23)00727-4"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nakamura I, Hatano E, Baba H, et al. Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer. Ann Gastroenterol Surg 2023; 7: 1009\u201320.","DOI":"10.1002\/ags3.12713"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Takahashi A, Yoshioka R, Koike S, et al. Feasibility of major hepatectomy following preoperative chemotherapy for advanced perihilar cholangiocarcinoma. Eur J Surg Oncol 2025; 51: 108733.","DOI":"10.1016\/j.ejso.2024.108733"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kosaka H, Matsui K, Ikeura T, et al. Prognostic impact of combination therapy with gemcitabine and cisplatin plus S-1 and subsequent conversion surgery for initially unresectable upper biliary tract cancers. Surg Today 2025; 55: 351\u20139.","DOI":"10.1007\/s00595-024-02912-z"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0555\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:52:41Z","timestamp":1766811161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.25-0555\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.25-0555","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.25-0555"}}